Nova Wealth Management, Inc. Nektar Therapeutics Transaction History
Nova Wealth Management, Inc.
- $142 Billion
- Q3 2025
A detailed history of Nova Wealth Management, Inc. transactions in Nektar Therapeutics stock. As of the latest transaction made, Nova Wealth Management, Inc. holds 16 shares of NKTR stock, worth $1,004. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 10
60.0%
Holding current value
$1,004
Previous $258,000
252.71%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NKTR
# of Institutions
20Shares Held
16.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY15.2MShares$952 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY491KShares$30.9 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL327KShares$20.5 Million0.0% of portfolio
-
Vista Wealth Management Group, LLC51.5KShares$3.23 Million0.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO12KShares$753,6000.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $11.8B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...